ImmunoPrecise Antibodies Ltd.

NASDAQ:IPA

0.46 (USD) • At close January 14, 2025
Bedrijfsnaam ImmunoPrecise Antibodies Ltd.
Symbool IPA
Munteenheid USD
Prijs 0.46
Beurswaarde 14,288,644
Dividendpercentage 0%
52-weken bereik 0.325 - 2.6
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jennifer Lynne Bath Ph.D.
Website https://www.ipatherapeutics.com

An error occurred while fetching data.

Over ImmunoPrecise Antibodies Ltd.

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research

Vergelijkbare Aandelen

Genenta Science S.p.A. logo

Genenta Science S.p.A.

GNTA

4.237 USD

Pieris Pharmaceuticals, Inc. logo

Pieris Pharmaceuticals, Inc.

PIRS

13.6 USD

Graphite Bio, Inc. logo

Graphite Bio, Inc.

GRPH

3.18 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.43 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.91 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.032 USD

CorMedix Inc. logo

CorMedix Inc.

CRMD

11.22 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)